FindTrial
Sign In

Abnormalities of thrombotic factor in children and adolescents hospitalized with a relapse of nephrotic syndrome

Evaluation of pro-thrombotic factors in children and adolescents hospitalized with a relapse of nephrotic syndrome - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/07/071421
Enrollment
40
Registered
2024-07-26
Start date
Unknown
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N049- Nephrotic syndrome with unspecified morphologic changes

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL

Sponsors

Department of Pediatrics Maulana Azad Medical College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Children and adolescents hospitalized with a relapse of nephrotic syndrome

Exclusion criteria

Exclusion criteria: 1. Presence of concomitant acute hepatitis/ liver disease 2. Already on anticoagulants 3. Patients admitted for renal biopsy 4. Congenital nephrotic syndrome

Design outcomes

Primary

MeasureTime frame
Proportion of patients with altered levels of antithrombin III, Protein C, Protein STimepoint: At admission and at discharge /2 weeks of hospitalization whichever is earlier—

Secondary

MeasureTime frame
Association of Prothrombotic factors with disease type, duration, therapy, presence of infection and hypovolemiaTimepoint: At admission and at discharge /2 weeks of hospitalization whichever is earlier;Proportion of patients with altered coagulation profile parameters (PT/INR/aPTT/Platelet count)Timepoint: At admission and at discharge /2 weeks of hospitalization whichever is earlier;Proportion of patients with altered D-Dimer, Fibrinogen and FDPTimepoint: At admission and at discharge /2 weeks of hospitalization whichever is earlier;Proportion of patients with presence of Factor V Leiden mutationTimepoint: At admission and at discharge /2 weeks of hospitalization whichever is earlier—

Countries

India

Contacts

Public ContactMansi Gupta

Maulana Azad Medical College

muktamantan@hotmail.com9968604315

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026